{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T10:49:50Z","timestamp":1779101390113,"version":"3.51.4"},"reference-count":105,"publisher":"Wiley","issue":"s3","license":[{"start":{"date-parts":[[2005,10,27]],"date-time":"2005-10-27T00:00:00Z","timestamp":1130371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hormonal adjuvants, besides being erythropoietic agents, broaden the spectrum of therapeutic options for the treatment of the anaemia of chronic kidney disease (CKD). Lowering elevated parathyroid hormone levels by oral calcium supplementation and phosphate restriction, by varying dialysate calcium concentrations, by administration of vitamin D<jats:sub>3<\/jats:sub> derivatives and, in the near future, by treatment with calcimimetics may prove efficient in some patients to fight extensive requirements of erythropoietic agents. Clinical evidence for a principal role of secondary hyperparathyroidism in resistance to erythropoietin, however, is lacking. Active vitamin D<jats:sub>3<\/jats:sub> derivatives, in addition to their beneficial effects on secondary hyperparathyroidism, appear to exert a direct, stimulatory action on erythroid precursor cells and possibly also an inhibitory action on collagen synthesis by bone marrow stromal cells. Growth hormone (GH) induces insulin\u2010like growth factor (IGF)\u20101, which in turn counteracts apoptosis similarly to erythropoietin, and fosters proliferation of burst\u2010 and colony\u2010forming units\u2010erythroid (BFU\u2010E, CFU\u2010E). If erythropoietic agents improve survival of CKD patients, a similar benefit should apply for strategies that increase synthesis and bioavailabilty of IGF\u20101. The latter appears to be reduced in CKD patients, and zinc supplementation potentially enhances it via an increase in free IGF\u20101. Finally, androgens also exert anti\u2010anaemic effects. Nandrolone decanoate constitutes the only androgen currently applicable for selected male dialysis patients over the age of 50\u00a0years. It should not be given to women, however, because of serious side effects. Collectively, hormonal interventions offer the potential to reduce requirements of erythropoietic agents, and some may also improve physical performance.<\/jats:p>","DOI":"10.1111\/j.1365-2362.2005.01533.x","type":"journal-article","created":{"date-parts":[[2005,10,27]],"date-time":"2005-10-27T16:25:40Z","timestamp":1130430340000},"page":"75-84","source":"Crossref","is-referenced-by-count":22,"title":["Hormonal adjuvants for the treatment of renal anaemia"],"prefix":"10.1111","volume":"35","author":[{"given":"R.","family":"Deicher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. H.","family":"H\u00f6rl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,10,27]]},"reference":[{"issue":"1","key":"e_1_2_3_2_2","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1016\/S0272-6386(01)70008-X","article-title":"K\/DOQI clinical practice guidelines for anemia of chronic kidney disease, 2000","volume":"37","author":"National Kidney Foundation.","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"e_1_2_3_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199301213280304"},{"key":"e_1_2_3_4_2","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1001\/archinte.1978.03630360038018","article-title":"Anemia and secondary hyperparathyroidism","volume":"138","author":"Zingraff J","year":"1978","journal-title":"Arch Intern Med"},{"key":"e_1_2_3_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.139.8.889"},{"key":"e_1_2_3_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.suppl_5.28"},{"key":"e_1_2_3_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.10.2708"},{"key":"e_1_2_3_8_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110154"},{"key":"e_1_2_3_9_2","first-page":"1016","article-title":"Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure","volume":"104","author":"McGonigle RJS","year":"1984","journal-title":"J Lab Clin Med"},{"key":"e_1_2_3_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.8.2088"},{"key":"e_1_2_3_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110505"},{"key":"e_1_2_3_12_2","doi-asserted-by":"publisher","DOI":"10.1159\/000044878"},{"key":"e_1_2_3_13_2","doi-asserted-by":"publisher","DOI":"10.1159\/000186596"},{"key":"e_1_2_3_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000188833"},{"key":"e_1_2_3_15_2","doi-asserted-by":"publisher","DOI":"10.1159\/000044877"},{"key":"e_1_2_3_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a092080"},{"key":"e_1_2_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(01)00865-0"},{"key":"e_1_2_3_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00282.x"},{"key":"e_1_2_3_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0838.1992.tb00312.x"},{"key":"e_1_2_3_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00599688"},{"key":"e_1_2_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91528-T"},{"key":"e_1_2_3_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.3.514"},{"key":"e_1_2_3_23_2","doi-asserted-by":"publisher","DOI":"10.5414\/CNP57487"},{"key":"e_1_2_3_24_2","first-page":"60","article-title":"Effect of 1,25 dihydroxyvitamin D3 and retinoic acid on normal human pluripotent (CFU\u2010mix), erythroid (BFU\u2010E), and myeloid (CFU\u2010C) progenitor cell growth and differentiation patterns","volume":"14","author":"Nagler A","year":"1986","journal-title":"Exp Hematol"},{"key":"e_1_2_3_25_2","first-page":"397","article-title":"Adverse effect of 1,25\u2010dihydroxycholecalciferol on erythrocyte precursors in the rat","volume":"36","author":"Orsatti MB","year":"1986","journal-title":"Acta Physiol Pharmacol Latinoam"},{"key":"e_1_2_3_26_2","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1182\/blood.V67.4.1154.1154","article-title":"Responses of hemopoietic precursors to 13\u2010cis retinoic acid and 1,25 dihydroxyvitamin D3 in the myelodysplastic syndromes","volume":"67","author":"Swanson G","year":"1986","journal-title":"Blood"},{"key":"e_1_2_3_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/stem.5530020403"},{"key":"e_1_2_3_28_2","first-page":"312","article-title":"Ca++ and 1,25(OH)2D3 regulate in vitro and in vivo the response to human recombinant erythropoietin in CAPD patients","volume":"6","author":"Carozzi S","year":"1990","journal-title":"Adv Perit Dial"},{"key":"e_1_2_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-128X(98)00102-0"},{"key":"e_1_2_3_30_2","first-page":"1","article-title":"Calcitriol increases burst forming unit\u2010erythroid (BFU\u2010E) in vitro proliferation in chronic uremia. Synergic effect with DNA recombinant erythropoietin (rHu\u2010Epo)","volume":"53","author":"Aucella F","year":"2001","journal-title":"Minerva Urol Nefrol"},{"key":"e_1_2_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(95)03707-4"},{"key":"e_1_2_3_32_2","doi-asserted-by":"crossref","unstructured":"AlonDB ChaimovitzC DvilanskyA LugassyG DouvdevaniA ShanySet al.Novel role of 1 25(OH)2D3in induction of erythroid progenitor cell proliferation.Exp Hematol2002;30: 403\u20139.","DOI":"10.1016\/S0301-472X(02)00789-0"},{"key":"e_1_2_3_33_2","first-page":"661","article-title":"Hematon: a multicellular functional unit in primary hematopoiesis","volume":"42","author":"Blazsek I","year":"1988","journal-title":"Biomed Pharmacother"},{"key":"e_1_2_3_34_2","first-page":"31","article-title":"Bone marrow stromal cell defects and 1 alpha, 25\u2010dihydroxyvitamin D3 deficiency underlying human myeloid leukemias","volume":"20","author":"Blazsek I","year":"1996","journal-title":"Cancer Detect Prev"},{"key":"e_1_2_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0753-3322(91)90103-Z"},{"key":"e_1_2_3_36_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2003.00131.x"},{"key":"e_1_2_3_37_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.76.3.648"},{"key":"e_1_2_3_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1991.tb12037.x"},{"key":"e_1_2_3_39_2","first-page":"551","article-title":"Acetate: inhibitor of growth hormone hypersecretion in diabetic and non\u2010diabetic uraemic subjects","volume":"99","author":"Orskov H","year":"1982","journal-title":"Acta Endocrinol (Copenh)"},{"key":"e_1_2_3_40_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.9.2985"},{"key":"e_1_2_3_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2001.01417.x"},{"key":"e_1_2_3_42_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1998.v32.pm9740162"},{"key":"e_1_2_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70223-4"},{"key":"e_1_2_3_44_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1380302"},{"key":"e_1_2_3_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-200303000-00003"},{"key":"e_1_2_3_46_2","doi-asserted-by":"publisher","DOI":"10.1177\/153537020322800101"},{"key":"e_1_2_3_47_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-63-5-1186"},{"key":"e_1_2_3_48_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-55-6-1040"},{"key":"e_1_2_3_49_2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1681\/ASN.V102315","article-title":"Insulin\u2010like growth factor I plays a role in regulating erythropoiesis in patients with end\u2010stage renal disease and erythrocytosis","volume":"10","author":"Shih LY","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_3_50_2","first-page":"40","article-title":"Insulin\u2010like growth factor I: a modulator of erythropoiesis in uremic patients?","volume":"7","author":"Urena P","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_3_51_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.18.6.801"},{"key":"e_1_2_3_52_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-59-4-764"},{"key":"e_1_2_3_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(87)80024-0"},{"key":"e_1_2_3_54_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.394"},{"key":"e_1_2_3_55_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02047.x"},{"key":"e_1_2_3_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.suppl_5.8"},{"key":"e_1_2_3_57_2","first-page":"303","article-title":"Nutritional regulation of IGF\u20101 and IGFBPs","volume":"9","author":"Underwood LE","year":"1996","journal-title":"J Pediatr Endocr Metab"},{"key":"e_1_2_3_58_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00018.x"},{"key":"e_1_2_3_59_2","first-page":"537","article-title":"Zinc metabolism in patients with the syndrome of iron deficiencies, anemia, hypogonadism, and dwarfism","volume":"61","author":"Prasad A","year":"1963","journal-title":"J Lab Clin Med"},{"key":"e_1_2_3_60_2","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/132.11.3301"},{"key":"e_1_2_3_61_2","first-page":"S269","article-title":"Factors underlying abnormal zinc metabolism in uremia","volume":"27","author":"Mahajan SK","year":"1989","journal-title":"Kidney Int Suppl"},{"key":"e_1_2_3_62_2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0002-8223(21)04118-3","article-title":"Taste perception of children with chronic renal failure","volume":"86","author":"Shapera MR","year":"1986","journal-title":"J Am Diet Assoc"},{"key":"e_1_2_3_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1986.227"},{"key":"e_1_2_3_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1986.tb02797.x"},{"key":"e_1_2_3_65_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1594.2000.06352.x"},{"key":"e_1_2_3_66_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03349889"},{"key":"e_1_2_3_67_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1982.106"},{"key":"e_1_2_3_68_2","first-page":"E21","article-title":"Influence of zinc on growth, somatomedin, and glycosaminoglycan metabolism in rats","volume":"252","author":"Bolze MS","year":"1987","journal-title":"Am J Physiol"},{"key":"e_1_2_3_69_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01952405"},{"key":"e_1_2_3_70_2","doi-asserted-by":"publisher","DOI":"10.1079\/BJN19910051"},{"key":"e_1_2_3_71_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1001718"},{"key":"e_1_2_3_72_2","doi-asserted-by":"publisher","DOI":"10.1079\/BJN19860096"},{"key":"e_1_2_3_73_2","first-page":"874","article-title":"The impaired growth induced by zinc deficiency in rats is associated with decreased expression of the hepatic insulin\u2010like growth factor 1 and growth hormone receptor genes","volume":"125","author":"McNall AK","year":"1995","journal-title":"J Nutr"},{"key":"e_1_2_3_74_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1440449"},{"key":"e_1_2_3_75_2","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/jn\/121.11.1763","article-title":"Compromised zinc status in rats adversely affects calcium metabolism in platelets","volume":"121","author":"O'Dell BL","year":"1991","journal-title":"J Nutr"},{"key":"e_1_2_3_76_2","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/124.3.436"},{"key":"e_1_2_3_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/0261-5614(91)90008-Z"},{"key":"e_1_2_3_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)81538-0"},{"key":"e_1_2_3_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90267-S"},{"key":"e_1_2_3_80_2","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.1999.10718861"},{"key":"e_1_2_3_81_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004240050317"},{"key":"e_1_2_3_82_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199811)59:3<230::AID-AJH8>3.0.CO;2-2"},{"key":"e_1_2_3_83_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.1997.00234.x"},{"key":"e_1_2_3_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)02397-X"},{"key":"e_1_2_3_85_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2003.98.5.0974"},{"key":"e_1_2_3_86_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.8.2670"},{"key":"e_1_2_3_87_2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1152\/jappl.1973.35.3.376","article-title":"Comparative study on the erythropoietic effects of androgens and their mode of action","volume":"35","author":"Gorsheim D","year":"1973","journal-title":"J Appl Physiol"},{"key":"e_1_2_3_88_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198104093041504"},{"key":"e_1_2_3_89_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365599609181318"},{"key":"e_1_2_3_90_2","doi-asserted-by":"publisher","DOI":"10.1159\/000188605"},{"key":"e_1_2_3_91_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1968.tb15169.x"},{"key":"e_1_2_3_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(72)90731-0"},{"key":"e_1_2_3_93_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1974.tb00466.x"},{"key":"e_1_2_3_94_2","doi-asserted-by":"publisher","DOI":"10.1159\/000181631"},{"key":"e_1_2_3_95_2","first-page":"173","article-title":"Influence of hormones on the release of iron by macrophages","volume":"29","author":"Reeves WB","year":"1981","journal-title":"J Reticuloendothel Soc"},{"key":"e_1_2_3_96_2","doi-asserted-by":"publisher","DOI":"10.1159\/000205683"},{"key":"e_1_2_3_97_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00271.x"},{"key":"e_1_2_3_98_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.1992.tb01118.x"},{"key":"e_1_2_3_99_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.77.3.776"},{"key":"e_1_2_3_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80246-0"},{"key":"e_1_2_3_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90307-3"},{"key":"e_1_2_3_102_2","first-page":"264","article-title":"A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis","volume":"37","author":"Berns JS","year":"1992","journal-title":"Clin Nephrol"},{"key":"e_1_2_3_103_2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1681\/ASN.V71140","article-title":"Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: a prospective study","volume":"7","author":"Teruel JL","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_3_104_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.14.1275"},{"key":"e_1_2_3_105_2","doi-asserted-by":"publisher","DOI":"10.1177\/039139880102400402"},{"key":"e_1_2_3_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90340-1"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2005.01533.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.2005.01533.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T16:50:07Z","timestamp":1695747007000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2005.01533.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,27]]},"references-count":105,"journal-issue":{"issue":"s3","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["10.1111\/j.1365-2362.2005.01533.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2005.01533.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,27]]}}}